Study of Dry Beriberi in Mayotte, Comoro Archipelago

Overview

The purpose of this study is to assess the existence of a genetic factor, suspected to be involved, aside from likely food deficiency contribution, in occurrence of dry beriberi, in patients who experienced dry beriberi and in a case group composed of 3 people, free from beriberi, within the same household.

Full Title of Study: “Determination Study of Dry Beriberi in Patients Native to the Comoro Archipelago, in Mayotte (MABECO).”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective

Detailed Description

A team of 2 investigators, a nurse and an investigator speaking French, Shibushi and Shimaore (3 languages in use in Mayotte), will visit exposed patients who agreed to participate to the study. 3 controls, fulfilling inclusion criteria, will be recruited within the household by drawing lots. Clinical examination and food survey by means of a questionnaire will be performed. Blood samples will be drawn to determine thiamine status, vitamin B1 dosage, erythrocyte transketolase activity and thiamine pyrophosphate effect, analysis will be performed by Biomnis laboratory in Lyon. For the genetic study, 4 drops of blood will be put down on Whatman paper and sent to Dr Johannes COY in Darmstadt Germany, for DNA extraction and PCR screening for mutations.

Arms, Groups and Cohorts

  • Patient
    • Native to the Comoro Archipelago (Grande Comore, Mayotte, Anjouan, Mohéli) fulfilling the clinical definition of the dry beriberi.
  • Control
    • Native to the Comoro Archipelago, living in the same household as the patient, sharing the same meals. Free from beriberi and with normal neurological examination.

Clinical Trial Outcome Measures

Primary Measures

  • Mutations on one of the alleles of the promoter of the gene TKTL1 (transketolase-like gene) in the homozygous state in the patients and not in the controls (heterozygotes or not carrier of the mutation).
    • Time Frame: day 1

Secondary Measures

  • To evaluate food intakes in vitamin B1 and anti-thiamine factors (polyphenols).
    • Time Frame: day 1
  • To evaluate Thiamine biological status (blood thiamine, erythrocyte transketolase activity and the thiamine pyrophosphate effect)
    • Time Frame: day 1

Participating in This Clinical Trial

Inclusion Criteria

  • patients – Native to the Comoro Archipelago (Grande Comore, Mayotte, Anjouan, Mohéli) – Fulfilling the clinical definition of the dry beriberi. – Both sexes. – Older than 15 years and 3 months (limit of the paediatrics). – Having signed and whose legal representatives signed the form of assent, having understood the information. – Benefiting from a social coverage regime. – Controls – Native to the Comoro Archipelago. – People living in the same household as the patient, sharing the same meals. – Both sexes. – Older than 15 years old and 3 months. – Free from beriberi. – With normal neurological examination. – Having signed and whose legal representatives signed the form of assent, having understood the information. – Benefiting from a social coverage regime. Exclusion Criteria:

  • Aged under 15-year-old and 3 months. – For the patients and the witnesses, the presence of pathologies known to increase needs in vitamin B1 (cancer, infectious diseases, fever, hyperthyroïdism, chronic alcoholism).

Gender Eligibility: All

Minimum Age: 15 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Groupe Hospitalier Sud Reunion
  • Provider of Information About this Clinical Study
    • Joaquin MARTINEZ / Clinical Research and Innovation Director, Regional Hospital, Reunion Island
  • Overall Official(s)
    • ERIC DOUSSIET, PHD, Principal Investigator, Regional Hospital La Reunion – CIC-EC
    • IAN PERINET, PHD, Principal Investigator, CENTRAL HOSPITAL MAYOTTE
    • JULIETTE WOESSNER, PHD, Principal Investigator, CENTRAL HOSPITAL MAYOTTE
    • Francoise DARCEL, PHD, Study Director, Regional Hospital La Reunion – GHSR
  • Overall Contact(s)
    • FRANCOISE DARCEL, PHD, +262 262 359 166, francoise.darcel@chr-reunion.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.